- $801.14m
- $929.71m
- $139.91m
Brief: Avid Bioservices Inc - On March 14, Co Entered Into A Credit Agreement
U.S. STOCKS ON THE MOVE-Mirum, AMC Entertainment, crypto stocks
U.S. STOCKS ON THE MOVE-Meta, Univar, Alphabet, Uber
Avid Bioservices gains as Q3 sales beat estimates
Avid Bioservices Inc reports results for the quarter ended in January - Earnings Summary
Brief: Avid Bioservices Reports Financial Results For Q3 Ended January 31, 2023, And Recent Developments
Brief: Avid Bioservices Q3 revenue USD 38 million
Avid Bioservices Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Avid Bioservices Inc Does Not Hold Any Cash Or Cash Equivalents At Svb And It Does Not Have Any Banking Relationship With Svb
Avid Bioservices Inc expected to post a loss of 3 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Churchill Downs, Mirati Therapeutics, Vivint Smart Home
Avid Bioservices drops after Q2 adj. EBITDA misses estimates
U.S. RESEARCH ROUNDUP- Autozone, Nike, Sachem Capital
Avid Bioservices Inc reports results for the quarter ended in October - Earnings Summary
Brief: Avid Bioservices Inc Reports Q2 Loss Per Share Of $0.02
Avid Bioservices Inc expected to post breakeven results a share - Earnings Preview
Brief: Avid Bioservices Reports Financial Results For First Quarter Ended July 31, 2022
Avid Bioservices Inc reports results for the quarter ended in July - Earnings Summary
Avid Bioservices Inc expected to post earnings of 4 cents a share - Earnings Preview